Janux Therapeutics (JANX) had the highest return between April 7, 2024 and April 14, 2024 by a small-cap US stock, returning 48.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Janux Therapeutics (JANX) | 4/7/2024 - 4/14/2024 | 48.48% |
Lyell Immunopharma (LYEL) | 4/7/2024 - 4/14/2024 | 41.98% |
OppFi (OPFI) | 4/7/2024 - 4/14/2024 | 31.15% |
Monopar Therapeutics (MNPR) | 4/7/2024 - 4/14/2024 | 30.17% |
Nektar Therapeutics (NKTR) | 4/7/2024 - 4/14/2024 | 24.63% |
NioCorp Developments Ltd Common Stock (NB) | 4/7/2024 - 4/14/2024 | 23.9% |
CorMedix (CRMD) | 4/7/2024 - 4/14/2024 | 23.21% |
Studio City International (MSC) | 4/7/2024 - 4/14/2024 | 19.21% |
Nurix Therapeutics (NRIX) | 4/7/2024 - 4/14/2024 | 18.56% |
Hycroft Mining (HYMC) | 4/7/2024 - 4/14/2024 | 16.97% |
GrafTech International (EAF) | 4/7/2024 - 4/14/2024 | 16.88% |
RAPT Therapeutics (RAPT) | 4/7/2024 - 4/14/2024 | 16.77% |
ProKidney (PROK) | 4/7/2024 - 4/14/2024 | 16.67% |
Americas Silver (USAS) | 4/7/2024 - 4/14/2024 | 15.38% |
Nextdecade (NEXT) | 4/7/2024 - 4/14/2024 | 11.67% |
Orthopediatrics (KIDS) | 4/7/2024 - 4/14/2024 | 11.43% |
LuxExperience (LUXE) | 4/7/2024 - 4/14/2024 | 11.28% |
Candel Therapeutics (CADL) | 4/7/2024 - 4/14/2024 | 11% |
Lands’ End (LE) | 4/7/2024 - 4/14/2024 | 10.95% |
Sharplink Gaming (SBET) | 4/7/2024 - 4/14/2024 | 10.77% |
UroGen Pharma (URGN) | 4/7/2024 - 4/14/2024 | 10.7% |
Taysha Gene Therapies (TSHA) | 4/7/2024 - 4/14/2024 | 10.53% |
Geron (GERN) | 4/7/2024 - 4/14/2024 | 9.64% |
Eyepoint Pharmaceuticals (EYPT) | 4/7/2024 - 4/14/2024 | 9.57% |
Diversified Energy (DEC) | 4/7/2024 - 4/14/2024 | 9.46% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
